A detailed history of Lountzis Asset Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Lountzis Asset Management, LLC holds 2,238 shares of JNJ stock, worth $350,761. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,238
Previous 1,421 57.49%
Holding current value
$350,761
Previous $207,000 74.88%
% of portfolio
0.15%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$145.48 - $167.38 $118,857 - $136,749
817 Added 57.49%
2,238 $362,000
Q1 2024

May 02, 2024

BUY
$155.22 - $162.74 $3,880 - $4,068
25 Added 1.79%
1,421 $224,000
Q4 2023

Jan 19, 2024

BUY
$145.6 - $158.88 $2,184 - $2,383
15 Added 1.09%
1,396 $218,000
Q1 2023

Apr 28, 2023

BUY
$151.05 - $180.26 $208,600 - $248,939
1,381 New
1,381 $214,000
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $159,337 - $192,365
1,237 New
1,237 $174,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Lountzis Asset Management, LLC Portfolio

Follow Lountzis Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lountzis Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lountzis Asset Management, LLC with notifications on news.